Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension

NCT01470144 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Epoprostenol

Sponsor

Actelion

Collaborators

[object Object]
[object Object]